Clinical Guidelines

Diabetes Risk Assessment: A New Approach

Blood-based epigenetic markers show strong prognostic potential for Type 2 diabetes

Share

  • 1

    New epigenetic markers could simplify prediabetes risk assessment.

  • 2

    Single blood draw replaces complex glucose tolerance tests.

  • 3

    Results promise early intervention for Type 2 diabetes.

  • 4

    DNA methylation profiles offer a predictive tool for metabolic decline.

  • 5

    Assessing risk clusters could reduce clinical burdens and costs.

Original Source(s)

Diabetes Risk Assessment: A New Approach

Blood-based epigenetic markers show strong prognostic potential for Type 2 diabetes

  • by Helen Bristow

  • March 9, 2026

  • 5 min

Related Content

AI Model Finds Hidden Risk Signals in CGM Data

GluFormer accurately identified patients likely to experience clinically meaningful rises in HbA1c over a 2-year period.

AI's Expanding Role in Diabetes Care

Machine learning models applied to inpatient electronic health record data have predicted insulin needs more accurately than traditional guidelines.

Stratifying Prediabetes by DNA

Blood-based methylation profiles reproduced high-risk clusters without complex metabolic testing.